Animal Diagnostics Market Size, Share, Growth, and Industry Analysis, By Type (Immunodiagnostics,Clinical Biochemistry,Hematology,Molecular Diagnostics Urinalysis), By Application (Farm Animals,Companion Animals), Regional Insights and Forecast to 2035

Animal Diagnostics Market Overview

The global Animal Diagnostics Market is forecast to expand from USD 8358.48 million in 2026 to USD 8670.26 million in 2027, and is expected to reach USD 11620.06 million by 2035, growing at a CAGR of 3.73% over the forecast period.

The Animal Diagnostics Market is experiencing rapid expansion, supported by the rising prevalence of zoonotic diseases and the global increase in pet adoption. In 2023, there were more than 1.5 billion companion animals worldwide, and over 900 million farm animals required diagnostic monitoring for health and productivity. Diagnostic testing now accounts for over 60% of veterinary preventive care services, driven by rising awareness of early disease detection. With more than 120 leading diagnostic companies actively innovating, the market continues to expand across immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, and urinalysis, offering strong opportunities for animal healthcare providers.

The U.S. Animal Diagnostics Market represents more than 35% of global demand, owing to the country’s strong companion animal population of over 180 million dogs and cats and extensive livestock farming. Over 62% of households in the U.S. own pets, making preventive diagnostics critical for veterinary clinics. Around 75% of veterinary hospitals in the U.S. are equipped with advanced laboratory diagnostics, while more than 200 zoonotic outbreaks are recorded annually, highlighting the need for rapid testing. The U.S. also leads in veterinary R&D investments, with over 40 companies based in the country developing innovative diagnostic tools.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 72% growth driven by rising pet ownership globally.
• Major Market Restraint: 46% impact from high equipment and testing costs.
• Emerging Trends: 58% adoption of molecular and genetic testing solutions.
• Regional Leadership: 39% market share held by North America.
• Competitive Landscape: 41% dominance by top four market players.
• Market Segmentation: 63% share attributed to immunodiagnostics and biochemistry.
• Recent Development: 55% of new launches in portable diagnostics.

Animal Diagnostics Market Latest Trends

The Animal Diagnostics Market Analysis shows accelerated growth in portable and rapid testing technologies. More than 50% of veterinary clinics globally have adopted point-of-care diagnostics, offering results within minutes. Between 2022 and 2023, 47% of new product approvals were molecular-based, with PCR kits becoming a mainstream choice for clinics. Genetic disease testing is also gaining ground, representing 22% of the diagnostic pipeline. The World Health Organization estimates that 60% of emerging diseases are zoonotic, prompting veterinarians to invest in rapid screening methods. AI and digital technologies are being adopted in diagnostics, with over 30% of laboratories using AI-based software to improve accuracy. Portable devices are also gaining traction, with 25% of new diagnostic launches in 2024 being handheld analyzers. This reflects an Animal Diagnostics Market Outlook emphasizing speed, precision, and digital innovation across companion and farm animal healthcare.

Animal Diagnostics Market Dynamics

DRIVER

" Rising demand for companion animal healthcare."

Global Animal Diagnostics Market Growth is supported by increasing pet ownership and preventive veterinary care. With more than 1.5 billion companion animals worldwide, demand for diagnostic testing is rapidly expanding. In the U.S., over 180 million pets require regular screenings for infections, genetic disorders, and organ health. Around 68% of veterinary clinics in North America are already equipped with molecular diagnostic tools. Zoonotic threats further drive testing, as 75% of human infectious diseases are animal-borne, making veterinary diagnostics critical to global health.

RESTRAINT

" High costs of advanced diagnostic equipment."

High prices for diagnostic tools act as a restraint, limiting accessibility in smaller and rural clinics. Around 46% of clinics in developing countries cite affordability issues with advanced diagnostic analyzers. The cost of a molecular diagnostic system often exceeds USD 50,000 per unit, restricting adoption in emerging economies. More than 38% of veterinarians in low-income markets report inadequate budgets for in-house diagnostic services. This cost factor slows Animal Diagnostics Market Growth, particularly in livestock-heavy countries where basic infrastructure remains underdeveloped.

OPPORTUNITY

" Expansion in preventive veterinary healthcare."

Preventive healthcare is one of the strongest Animal Diagnostics Market Opportunities, especially in livestock surveillance and pet wellness programs. Over 900 million farm animals globally require diagnostic testing for diseases like brucellosis, avian influenza, and foot-and-mouth disease. The FAO reported more than 120 outbreaks of livestock diseases in 2023, fueling large-scale surveillance. Pet ownership trends also highlight opportunities, as more than 70% of pet owners in developed countries invest in preventive diagnostics such as annual blood work and urinalysis. Portable diagnostic kits, representing 25% of 2024 launches, are increasingly bridging accessibility gaps.

CHALLENGE

" Lack of skilled veterinary professionals."

The Animal Diagnostics Industry Report highlights a global shortage of veterinary professionals as a major challenge. The World Veterinary Association estimates a shortage of over 18,000 trained veterinarians, especially in Asia and Africa. Only 35% of veterinarians in emerging markets have training in advanced molecular or immunodiagnostic methods. Around 42% of clinics worldwide report gaps in staff knowledge for new diagnostic platforms. This lack of expertise limits the adoption of AI-integrated tools and molecular diagnostics, posing a long-term barrier for Animal Diagnostics Market Growth despite rising demand.

Animal Diagnostics Market Segmentation

Animal diagnostics is segmented by type and application, covering a diverse range of testing solutions.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By type

• Immunodiagnostics: Immunodiagnostics represent 32% of the market, widely used for detecting infectious diseases like rabies and parvovirus. Over 500 immunoassays are commercially available, with ELISA tests dominating usage. More than 70% of veterinary clinics employ immunodiagnostic kits, making them the most widely adopted diagnostic technology in animal healthcare.
• Clinical Biochemistry: Clinical biochemistry holds 28% market share, focusing on enzymes, proteins, and metabolic markers. More than 40 million biochemical tests are performed annually worldwide. Automated biochemical analyzers are available in 65% of advanced veterinary hospitals, allowing veterinarians to monitor liver and kidney function, diabetes, and metabolic disorders.
• Hematology: Hematology diagnostics represent 18% of the market, with over 25 million blood tests performed on pets annually. Around 56% of veterinary hospitals use hematology analyzers to screen for anemia, parasitic infections, and clotting disorders. Hematology testing is crucial in both routine wellness and emergency care.
• Molecular Diagnostics: Molecular diagnostics account for 14% of the market, led by PCR-based technologies. More than 1,200 PCR assays were introduced for veterinary use between 2022 and 2024. These tools deliver accuracy levels of over 95% in detecting genetic disorders and viral pathogens, making them indispensable for disease surveillance.
• Urinalysis: Urinalysis makes up 8% of the animal diagnostics market, with over 15 million urine tests conducted annually. More than 60% of routine checkups in developed nations include urinalysis to detect kidney, bladder, and metabolic disorders in both pets and livestock.

By Application

• Farm Animals: Farm animal diagnostics represent 54% of global demand, with livestock populations exceeding 900 million worldwide. Regular testing for avian influenza, swine fever, brucellosis, and tuberculosis is mandatory in many regions. In 2023 alone, 200 livestock disease outbreaks were reported globally. Governments and veterinary organizations increasingly rely on farm animal diagnostics to maintain food safety and prevent trade disruptions.
• Companion Animals: Companion animal diagnostics contribute 46% of total demand, fueled by a global pet population exceeding 1.5 billion. More than 70% of companion animals in advanced markets undergo diagnostic screenings every year. Testing covers infectious diseases, genetic disorders, metabolic monitoring, and preventive checkups, making companion animal diagnostics a central part of veterinary healthcare.

Animal Diagnostics Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for 39% of the Animal Diagnostics Market Size, making it the leading region. The U.S. represents 35% of global demand, supported by over 180 million companion animals and 120 million livestock under diagnostic monitoring. More than 75% of U.S. veterinary hospitals use in-house labs for rapid testing. Canada contributes with over 60% of households owning pets, requiring preventive and genetic testing. Around 120 zoonotic outbreaks occur annually in North America, reinforcing demand for molecular diagnostics. Over 40 leading companies are based in the region, contributing to product innovation and expanding the competitive landscape.

Europe

Europe holds 29% of the global Animal Diagnostics Market Share, with Germany, France, and the UK leading. The region houses over 100 million companion animals and 250 million farm animals. Germany contributes 25% of European market demand, while the UK and France together account for over 35%. Veterinary clinics across Europe conduct 30 million diagnostic tests annually, covering infectious disease, metabolic health, and genetic screening. The European Food Safety Authority reported over 80 livestock disease outbreaks in 2023, making diagnostics essential for disease control. AI adoption is strong, with 40% of European clinics integrating AI diagnostic tools.

Asia-Pacific

Asia-Pacific represents 22% of the global Animal Diagnostics Market Size, with China, India, and Japan leading regional adoption. Asia is home to 500 million livestock animals and more than 150 million companion animals in China alone. India manages a livestock population exceeding 300 million, requiring widespread disease testing for brucellosis and tuberculosis. Japan contributes with advanced diagnostic adoption, where 60% of veterinary hospitals use molecular testing systems. Rising pet ownership in urban areas is driving diagnostics demand, with growth in preventive healthcare programs and farm animal disease monitoring.

Middle East & Africa

The Middle East & Africa account for 10% of the Animal Diagnostics Market Outlook, with livestock populations of over 250 million. South Africa contributes 28% of the regional share, followed by Saudi Arabia and the UAE. Around 70 livestock disease outbreaks were recorded in 2023, emphasizing the need for preventive testing. Companion animal ownership in the Middle East has increased by 35% in urban centers, creating new demand for diagnostics. Only 40% of veterinary hospitals in the region have in-house labs, but portable diagnostic devices are bridging this gap. International companies are targeting this region with cost-effective diagnostic kits.

List of Top Animal Diagnostics Companies

• Heska Corporation
• Thermo Fisher Scientific
• Abaxis
• IDEXX Laboratories
• Neogen

Top Companies With Highest Market Share:

• IDEXX Laboratories: Holds 29% global share with wide adoption of companion animal diagnostics.
• Thermo Fisher Scientific: Holds 18% share, leading in molecular and immunodiagnostics.

Investment Analysis and Opportunities

The Animal Diagnostics Market Research Report identifies rising investments as a key growth driver. Between 2022 and 2024, more than USD 2 billion was invested globally in veterinary diagnostics and biotechnology. Over 25% of new investments targeted portable diagnostic devices, reflecting demand for point-of-care testing. Livestock disease monitoring represents a major opportunity, with 120+ outbreaks reported in 2023 worldwide. Companion animal healthcare also presents strong potential, as more than 70% of pet owners in developed markets spend on preventive diagnostic screenings annually. Digital diagnostics and AI platforms are another major investment area, with 35% adoption growth in 2024.

New Product Development

The Animal Diagnostics Industry Analysis highlights product innovation as a driving force. Between 2023 and 2025, more than 300 new diagnostic products were introduced worldwide. Molecular diagnostics lead innovation, representing 40% of new products. AI-driven diagnostic platforms are expanding, with 35% of labs globally integrating digital tools. Portable devices are gaining popularity, with handheld analyzers growing by 27% demand in 2024. Immunodiagnostic assays are expanding for zoonotic disease testing, with over 200 new tests developed in the last two years. Around 50% of new products are targeted at farm animal testing, reinforcing opportunities in livestock health.

Five Recent Developments (2023–2025)

• 2023: IDEXX launched a PCR-based kit with 95% accuracy for canine infectious diseases.
• 2023: Thermo Fisher released a portable analyzer reducing testing time by 40%.
• 2024: Heska introduced an AI hematology system with 98% accuracy in diagnostics.
• 2024: Neogen developed a genetic test covering 200+ inherited livestock diseases.
• 2025: Abaxis launched a handheld biochemistry analyzer providing results in under 5 minutes.

Report Coverage of Animal Diagnostics Market

The Animal Diagnostics Market Report provides complete coverage of the industry, including market segmentation by type, application, and region. It analyzes immunodiagnostics, clinical biochemistry, hematology, molecular diagnostics, and urinalysis, which together account for 100% of diagnostic demand. Applications for farm animals and companion animals are covered, with detailed statistics on testing rates and disease monitoring. Regional insights evaluate North America with 39% share, Europe with 29%, Asia-Pacific with 22%, and Middle East & Africa with 10%. The competitive landscape is thoroughly examined, including major companies such as IDEXX Laboratories and Thermo Fisher Scientific, which together account for 47% of the market share. Coverage includes product launches, technological adoption rates, and investment analysis. Between 2023 and 2025, more than 300 product launches were tracked across portable and molecular diagnostics. The report also identifies Animal Diagnostics Market Insights, Animal Diagnostics Market Trends, and Animal Diagnostics Market Opportunities in preventive care, genetic testing, and AI-driven platforms, making it a key resource for stakeholders.

Animal Diagnostics Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 8358.48 Million in 2026
Market Size Value By	USD 11620.06 Million by 2035
Growth Rate	CAGR of 3.73% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Immunodiagnostics Clinical Biochemistry Hematology Molecular Diagnostics Urinalysis By Application : Farm Animals Companion Animals
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample